I now have all the core content needed for a comprehensive overview. Let me compile the full answer.
Neoplasia: Overview, Definitions, Classification & Nomenclature
Based on Robbins & Kumar Basic Pathology, 10th Edition
1. What is Neoplasia?
Neoplasm (Greek: neos = new, plasma = formation) is defined as an abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of the normal tissues, and persists in the same excessive manner after cessation of the stimuli that evoked the change. This classic definition (Willis) emphasizes three points:
- Growth is autonomous - does not respond to normal regulatory controls
- Growth is excessive - disproportionate to normal tissue growth
- Growth persists even after the triggering stimulus is removed
Modern understanding adds: cancer is fundamentally a genetic disorder caused by DNA mutations that dysregulate key cellular processes (growth, survival, senescence). These mutations are heritable (passed to daughter cells) and subject to Darwinian selection, producing clonal tumors that undergo progressive genetic evolution.
2. Components of a Neoplasm
Every tumor has two basic components:
| Component | Description |
|---|
| Parenchyma | The neoplastic (clonal) cells - determines biological behavior and names the tumor |
| Stroma | Supportive connective tissue, blood vessels, and inflammatory cells - non-neoplastic; essential for tumor growth and spread |
3. Nomenclature
Benign Tumors
Named by attaching the suffix -oma to the cell of origin:
| Cell of Origin | Benign Tumor |
|---|
| Fibroblast | Fibroma |
| Chondrocyte | Chondroma |
| Osteocyte | Osteoma |
| Adipocyte | Lipoma |
| Smooth muscle | Leiomyoma |
| Striated muscle | Rhabdomyoma |
| Blood vessel | Hemangioma |
| Lymph vessel | Lymphangioma |
| Glandular epithelium | Adenoma |
| Glandular epithelium forming cysts | Cystadenoma |
| Epithelium forming finger-like projections | Papilloma |
Malignant Tumors
Named based on cell of origin:
- Carcinoma - malignant tumors of epithelial origin
- Adenocarcinoma - glandular epithelium
- Squamous cell carcinoma - stratified squamous epithelium
- Sarcoma - malignant tumors of mesenchymal origin (connective tissue, muscle, bone)
- Fibrosarcoma, Liposarcoma, Chondrosarcoma, Osteosarcoma, Leiomyosarcoma, Rhabdomyosarcoma
- Leukemia/Lymphoma - malignant tumors of hematopoietic and lymphoid tissue
Exceptions and Eponyms (important to know)
| Tumor Name | Actual Nature |
|---|
| Melanoma | Malignant (despite -oma suffix) |
| Mesothelioma | Malignant |
| Seminoma | Malignant |
| Lymphoma | Malignant |
| Hepatoma | Malignant (= hepatocellular carcinoma) |
| Glioblastoma | Malignant |
| Ewing sarcoma | Malignant (eponym) |
| Wilms tumor | Malignant (eponym) |
| Kaposi sarcoma | Malignant (eponym) |
| Hamartoma | Benign (disorganized tissue elements normal to that site) |
| Choristoma | Benign (normal tissue in an abnormal location) |
4. Classification: Benign vs. Malignant
The most important distinction in pathology. Based on 4 major characteristics:
4.1 Differentiation and Anaplasia
| Feature | Benign | Malignant |
|---|
| Differentiation | Well differentiated; resembles parent tissue | Variable; poorly to undifferentiated (anaplastic) |
| Nuclear morphology | Normal size/shape | Pleomorphism (variation in size and shape), hyperchromasia, prominent nucleoli |
| N:C ratio | Normal (1:4 to 1:6) | Increased (1:1 in anaplastic tumors) |
| Mitoses | Rare, normal forms | Frequent, abnormal (tripolar/quadripolar) mitotic figures |
| Architecture | Maintains normal tissue architecture | Disorganized, anarchic |
Anaplasia = lack of differentiation; a hallmark of malignancy. Anaplastic cells show:
- Marked pleomorphism (variation in cell and nuclear size/shape)
- Abnormal nuclear morphology (hyperchromatic, large nuclei)
- Atypical tumor giant cells (one or more large, bizarre nuclei)
- Loss of polarity (cells don't organize in normal orientation)
Dysplasia = disordered growth; NOT synonymous with malignancy, but represents a potential precursor (especially in epithelium - cervical intraepithelial neoplasia, Barrett's esophagus). When dysplasia affects full thickness of epithelium without invasion = carcinoma in situ (CIS).
4.2 Rate of Growth
| Benign | Malignant |
|---|
| Growth rate | Slow, progressive | Variable - often rapid |
| Mitotic rate | Low | High |
| Consistency | May regress/stay static | Rarely regresses spontaneously |
Growth rate generally correlates with degree of differentiation - undifferentiated (anaplastic) tumors tend to grow fastest.
4.3 Local Invasion
| Benign | Malignant |
|---|
| Capsule | Usually encapsulated | Usually NOT encapsulated |
| Growth pattern | Expansile (pushes, compresses adjacent tissue) | Infiltrative (invades and destroys adjacent tissue) |
| Plane of dissection | Clear surgical plane exists | No clear plane; surgery must include wide margins |
Note: Some benign tumors are NOT encapsulated (e.g., hemangiomas), but malignant tumors are NEVER truly encapsulated.
4.4 Metastasis
Metastasis = the ability to spread to distant sites. This is the single feature that definitively marks a tumor as malignant. Benign tumors never metastasize.
Routes of metastasis:
- Lymphatic spread - most common for carcinomas; goes to regional lymph nodes first
- Hematogenous spread - most common for sarcomas; via veins (thin-walled); liver and lung most common sites
- Seeding of body cavities (transcoelomic) - e.g., ovarian carcinoma seeding the peritoneum
5. Tumor Classification by Tissue of Origin (Summary Table)
| Tissue of Origin | Benign | Malignant |
|---|
| Connective tissue | | |
| Fibrous tissue | Fibroma | Fibrosarcoma |
| Adipose | Lipoma | Liposarcoma |
| Cartilage | Chondroma | Chondrosarcoma |
| Bone | Osteoma | Osteosarcoma |
| Endothelium/Related | | |
| Blood vessels | Hemangioma | Angiosarcoma |
| Lymph vessels | Lymphangioma | Lymphangiosarcoma |
| Mesothelium | - | Mesothelioma |
| Brain coverings | Meningioma | Invasive meningioma |
| Blood/Lymphoid | | |
| Hematopoietic cells | - | Leukemias |
| Lymphoid tissue | - | Lymphomas |
| Muscle | | |
| Smooth muscle | Leiomyoma | Leiomyosarcoma |
| Striated muscle | Rhabdomyoma | Rhabdomyosarcoma |
| Epithelial | | |
| Squamous | Squamous cell papilloma | Squamous cell carcinoma |
| Basal cells (skin) | - | Basal cell carcinoma |
| Melanocytes | Nevus | Melanoma |
| Glandular epithelium | Adenoma / Cystadenoma | Adenocarcinoma / Cystadenocarcinoma |
| Urothelium | Urothelial papilloma | Urothelial carcinoma |
| Liver | Hepatic adenoma | Hepatocellular carcinoma |
| Kidney | Renal tubular adenoma | Renal cell carcinoma |
| Placenta | Hydatidiform mole | Choriocarcinoma |
| Testis | - | Seminoma |
| Mixed/Germ Cell | | |
| All three germ layers | Mature teratoma (dermoid) | Immature teratoma |
| Salivary gland (epithelium + myoepithelium) | Pleomorphic adenoma | Malignant mixed tumor |
6. Special Tumor Categories
Teratoma
Derived from totipotent germ cells; contains tissues from more than one germ layer (ecto-, meso-, endoderm). Found in gonads (ovary, testis) and midline structures.
- Mature teratoma (dermoid cyst) = benign; contains well-differentiated adult-type tissues
- Immature teratoma = malignant; contains embryonic-type tissues
Hamartoma vs. Choristoma
- Hamartoma: mass of disorganized but mature tissue normal to that anatomic site (e.g., pulmonary hamartoma with cartilage, smooth muscle, vessels - all normal lung constituents)
- Choristoma (heterotopia): normal tissue found at an abnormal site (e.g., pancreatic tissue in the stomach wall) - not truly neoplastic
Mixed Tumors
Contain two cell types arising from one germ layer:
- Pleomorphic adenoma of parotid: epithelial + myoepithelial cells - both arise from salivary gland epithelium
- Fibroadenoma of breast: glandular + stromal elements
7. Key Definitions Summary
| Term | Definition |
|---|
| Neoplasm | Abnormal autonomous tissue mass; growth uncoordinated and persists after stimulus |
| Tumor | Literally "swelling"; used synonymously with neoplasm |
| Cancer | Common term for any malignant neoplasm |
| Carcinoma | Malignant epithelial tumor |
| Sarcoma | Malignant mesenchymal tumor |
| Anaplasia | Loss of differentiation; hallmark of malignancy |
| Dysplasia | Disordered cell growth; precancerous change |
| Carcinoma in situ | Full-thickness dysplasia without basement membrane invasion |
| Desmoplasia | Fibrous stroma elicited by malignant tumor |
| Metastasis | Tumor spread to distant sites; defines malignancy |
| Paraneoplastic syndrome | Symptoms caused by hormones/cytokines secreted by tumor, NOT by direct tumor invasion |
Robbins & Kumar Basic Pathology, 10th Ed., Chapter on Neoplasia, pp. 187-229